ArticleFrontiers in oncology2025
EnSLDe: an enhanced short-range and long-range dependent system for brain tumor classification.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MLG: a mixed local and global model for brain tumor classification.Frontiers in neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Brain tumors pose significant harm to the functionality of the human nervous system. There are lots of models which can classify brain tumor type. However, the available methods did not pay special attention to long-range information, which limits model accuracy improvement. Methods: To solve this problem, in this paper, an enhanced short-range and long-range dependent system for brain tumor classification, named as EnSLDe, is proposed. The EnSLDe model consists of three main modules: the Feature Extraction Module (FExM), the Feature Enhancement Module (FEnM), and the Classification Module. Firstly, the FExM is used to extract features and the multi-scale parallel subnetwork is constructed to fuse shallow and deep features. Then, the extracted features are enhanced by the FEnM. The FEnM can capture the important dependencies across a larger sequence range and retain critical information at a local scale. Finally, the fused and enhanced features are input to the classification module for brain tumor classification. The combination of these modules enables the efficient extraction of both local and global contextual information. Results: In order to validate the model, two public data sets including glioma, meningioma, and pituitary tumor were validated, and good experimental results were obtained, demonstrating the potential of the model EnSLDe in brain tumor classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.